Flynn James E 13D and 13G filings for Abeona Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 5:23 pm Sale | 2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO | Flynn James E | 869,565 3.390% | -869,565 (-50.00%) | Filing |
| 2023-02-10 09:58 am Unchanged | 2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO | Flynn James E | 1,739,130 5.060% | 0 (Unchanged) | Filing |
| 2022-11-16 4:47 pm Purchase | 2022-11-07 | 13G | Abeona Therapeutics Inc. ABEO | Flynn James E | 1,739,130 5.060% | 1,739,130 (New Position) | Filing |